T cell therapies work by transplanting engineered T cells that can recognize and bind to naturally occuring antigens on the surface of cancer cells. CAR T therapy is already approved for treating ...

"Their cells are enshrouded by a dense ... "We can now predict which antigen is activated next and appears on the surface of trypanosomes," says Colomé-Tatché. In addition to experts from ...

T cells, move over. B cells are now reported ... but many may also be moved to the surface as intact antigens. A number of pathogens can initiate the mannan-binding lectin and alternative pathways ...

HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on ...

A new study by LMU and Helmholtz Munich shows how the pathogen Trypanosoma brucei controls changes in its cell surface to evade the immune ...

A team at Baylor College of Medicine conducted research to identify novel cell-surface cancer/germline antigens (CGAs) expressed in triple-negative breast cancer (TNBC) that could serve as targets for ...

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of ...

T cells are precisely tuned to recognize molecules on the surface of cancer cells – called antigens – and use them as signals ...